http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/philips-issues-recall-notification-mitigate-potential-health-risks-related-sound-abatement-foam

Importation of COVID-19 Vaccine Moderna with up to 15 Doses per Vial and English-only Vial and Carton Labels (US-Labelled Supply)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75807a-eng.php

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2118-se-habilita-sistema-de-notificacion-de-contactos-covid-19-creado-por-google-y-apple

Coronavirus (COVID-19) Update: June 11, 2021
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-june-11-2021

FDA Takes Steps to Increase Availability of COVID-19 Vaccine
http://www.fda.gov/news-events/press-announcements/fda-takes-steps-increase-availability-covid-19-vaccine

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2117-salud-emite-nuevo-lineamiento-para-certificacion-de-vacunas-colocadas-en-costa-rica-y-en-el-extranjero

RUZURGI (amifampridine) – Removal from Canadian Market: Options for Continued Treatment for Lambert-Eaton Myasthenic Syndrome
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75793a-eng.php

http://www.fda.gov/medical-devices/safety-communications/stop-using-innova-sars-cov-2-antigen-rapid-qualitative-test-fda-safety-communication

http://www.fda.gov/medical-devices/medical-device-recalls/innova-medical-group-recalls-unauthorized-sars-cov-2-antigen-rapid-qualitative-test-risk-false-test

FDA In Brief: FDA Provides Guidance on Measuring Patient-Reported Outcomes in Cancer Clinical Trials
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-provides-guidance-measuring-patient-reported-outcomes-cancer-clinical-trials